
| |
The
safety of pharmaceutical excipients (304 Ko - pdf)
Il Farmaco (2003) 58:541-550
Giorgio Pifferi, Patrizia Restani
Innovation
and placebos in research : a new design of clinical trial (62 Ko - pdf)
The Lancet (2003) 362: 2036-7 [December 20/27]
Anne Holbrook, Charles Goldsmith
The
placebo standard in regulatory market approval : why the declaration of Helsinki
has been ignored for 35 years (22 Ko - pdf)
McGill Journal of Medicine (2001) 6: 52-55
Patrick James Villeneuve Comment
prévenir le risque thérapeutique médicamenteux (62 Ko - pdf)
Rev Med Interne (2001) 22:1237-43
Gilles Bouvenot The
proposed guidelines for the safety evaluation of new excipients (919 Ko -
pdf)
European Pharmaceutical Review - Novembre 1997
IPEC European safety committee
Pravastatin
in elderly individuals at risk of vascular disease (PROSPER)
:
a randomised controlled trial (107 Ko - pdf)
The Lancet (2002) 360: 1623-1630
James Shepherd, Gerard J Blauw, Michael B Murphy, Edward L E M Bollen,
Brendan M Buckley, Stuart M Cobbe, Ian Ford, Allan Gaw, Michael Hyland,
J Wouter Jukema, Adriaan M Kamper, Peter W Macfarlane, A Edo Meinders,
John Norrie, Chris J Packard, Ivan J Perry, David J Stott, Brian J Sweeney,
Cillian Twomey, Rudi G J Westendorp, on behalf of the PROSPER study group
création le 24 janvier 2003
dernière modification le
11 juillet 2005
|